Document is current
Any future updates will be listed below
-
Authors
Imai, Risako
Sakai, Mayu
Kato, Takehiro
Ozeki, Sayako
Kubota, Sodai
Liu, Yanyan
Takahashi, Yoshihiro
Takao, Ken
Mizuno, Masami
Hirota, Takuo
Horikawa, Yukio
Murakami, Takaaki
Kanayama, Tomohiro
Kuroda, Takahiro
Miyazaki, Tatsuhiko
Yabe, Daisuke
- License Information
-
More Information
Article History
Received: 6 November 2023
Accepted: 18 August 2024
First Online: 20 September 2024
Declarations
:
: DY has received consulting/lecture fees from Novo Nordisk Pharma Ltd., Nippon Boehringer Ingelheim, Eli Lilly Japan K.K., and Kyowa Kirin Co., Ltd. DY also received grants from Arkray Inc., Novo Nordisk Pharma Ltd., Nippon Boehringer Ingelheim, Taisho Pharmaceutical Co. Ltd., and Terumo Corporation. YH has received lecture fees from Sumitomo Pharma Co. Ltd. RI, MS, TK, SO, SK, YL, YT, KT, MM, TH, TM, TK, TK, and TM declare that they have no conflict of interest. All authors declare that they have no competing interests relevant to this study.
: Formal ethics approval was waived for this paper by the ethics committee of Gifu University Graduate School of Medicine due to its being a case report.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
